Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Carboxymaltose for Glucose Homeostasis in Iron-Deficient Women
NCT03191201Phase 4Terminated
- Start
- Jun 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Ferric carboxymaltose arm with Placebo arm (2 arms). Primary endpoint: Change from baseline in glucose homeostasis status at 28 days. Started Jun 2017; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03191201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03191201.